Improving stroke care in the Rhine-Neckar region
Schlaganfallkonsortium Rhein-Neckar (Stroke Consortium Rhine-Neckar)
This study is trying to improve care for people who have had a stroke in Germany by collecting data from hospitals to see how treatment can be better and faster.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 12000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital Heidelberg Academic / other |
| Locations | 1 site (Heidelberg) |
| Trial ID | NCT03157934 on ClinicalTrials.gov |
What this trial studies
This observational study aims to enhance the quality of care for ischemic stroke patients within a regional stroke network in Germany. It will establish a comprehensive patient registry that collects data from approximately 12,000 acute ischemic stroke patients annually across 30 hospitals. The study focuses on identifying candidates for thrombectomy, optimizing treatment procedures, and improving pre-hospital selection and referral processes. By integrating clinical data from various phases of care, the study seeks to address critical questions regarding resource allocation and treatment efficacy.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 years or older who are admitted with ischemic stroke to participating hospitals.
Not a fit: Patients who cannot provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved outcomes and more efficient care for stroke patients in the region.
How similar studies have performed: Other studies have shown success in improving stroke care through integrated networks, making this approach both relevant and promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years or older * Patients with ischemic stroke who are admitted to one of the hospitals of the Stroke Consortium Rhein-Neckar (FAST) * informed consent Exclusion Criteria: * no informed consent
Where this trial is running
Heidelberg
- Heidelberg University Hospital — Heidelberg, Germany (Recruiting)
Study contacts
- Principal investigator: Wolfgang Wick, Prof. Dr. — University Hospital Heidelberg
- Study coordinator: Loraine Busetto, Dr.
- Email: loraine.busetto@med.uni-heidelberg.de
- Phone: +49622156
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.